BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 7893282)

  • 1. Age-related and gender-related occurrence of pituitary adenomas.
    Mindermann T; Wilson CB
    Clin Endocrinol (Oxf); 1994 Sep; 41(3):359-64. PubMed ID: 7893282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric pituitary adenomas.
    Mindermann T; Wilson CB
    Neurosurgery; 1995 Feb; 36(2):259-68; discussion 269. PubMed ID: 7731505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ghrelin and growth hormone (GH) secretagogue receptor (GHSR) mRNA expression in human pituitary adenomas.
    Kim K; Arai K; Sanno N; Osamura RY; Teramoto A; Shibasaki T
    Clin Endocrinol (Oxf); 2001 Jun; 54(6):759-68. PubMed ID: 11422110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of thyrotrophin-releasing hormone receptor 1 messenger ribonucleic acid in human pituitary adenomas.
    Kim K; Arai K; Sanno N; Teramoto A; Shibasaki T
    Clin Endocrinol (Oxf); 2001 Mar; 54(3):309-16. PubMed ID: 11298082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electron microscopical morphometry of well-differentiated and undifferentiated ACTH secreting adenomas in Cushing's disease and Nelson's syndrome.
    Reuss WA; Saeger W; Lüdecke DK
    Virchows Arch A Pathol Anat Histopathol; 1991; 419(5):395-401. PubMed ID: 1661044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone and prolactin responses to corticotrophin-releasing-hormone in patients with Cushing's disease: a paracrine action of the adenomatous corticotrophic cells?
    Loli P; Boccardi E; Branca V; Bramerio M; Barberis M; Losa M; Terreni MT; Lodrini S; Pollo B; Vignati F
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):433-9. PubMed ID: 9876339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin secretion by mixed ACTH-prolactin pituitary adenoma cells in culture.
    Yamaji T; Ishibashi M; Teramoto A; Fukushima T
    Acta Endocrinol (Copenh); 1985 Apr; 108(4):456-63. PubMed ID: 2859725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pit-1 gene expression in human pituitary adenomas using the reverse transcription polymerase chain reaction method.
    Yamada S; Takahashi M; Hara M; Hattori A; Sano T; Ozawa Y; Shishiba Y; Hirata K; Usui M
    Clin Endocrinol (Oxf); 1996 Sep; 45(3):263-72. PubMed ID: 8949563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pituitary adenomas in patients with multiple endocrine neoplasia type 1: a single-center experience in China.
    Wu Y; Gao L; Guo X; Wang Z; Lian W; Deng K; Lu L; Xing B; Zhu H
    Pituitary; 2019 Apr; 22(2):113-123. PubMed ID: 30637623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The incidence rate of pituitary adenomas in western Sweden for the period 2001-2011.
    Tjörnstrand A; Gunnarsson K; Evert M; Holmberg E; Ragnarsson O; Rosén T; Filipsson Nyström H
    Eur J Endocrinol; 2014 Oct; 171(4):519-26. PubMed ID: 25084775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary adenomas. An immunohistochemical study of hormone production and chromogranin localization.
    DeStephano DB; Lloyd RV; Pike AM; Wilson BS
    Am J Pathol; 1984 Sep; 116(3):464-72. PubMed ID: 6089568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of the thyrotrophin-releasing hormone receptor in human pituitary adenomas.
    Faccenda E; Melmed S; Bevan JS; Eidne KA
    Clin Endocrinol (Oxf); 1996 Mar; 44(3):341-7. PubMed ID: 8729534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of pituitary adenomas].
    Mezosi E; Nemes O
    Orv Hetil; 2009 Sep; 150(39):1803-10. PubMed ID: 19758960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of the alpha-subunit of glycoprotein hormones by pituitary adenomas.
    Landolt AM; Heitz PU; Zenklusen HR
    Pathol Res Pract; 1988 Sep; 183(5):610-2. PubMed ID: 2467270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prolactin levels in patients with Cushing's disease without pathological evidence of pituitary adenoma.
    Comtois R; Beauregard H; Hardy J; Robert F; Somma M
    Clin Endocrinol (Oxf); 1993 Jun; 38(6):601-7. PubMed ID: 8392915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data.
    Buurman H; Saeger W
    Eur J Endocrinol; 2006 May; 154(5):753-8. PubMed ID: 16645024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The release of leptin and its effect on hormone release from human pituitary adenomas.
    Korbonits M; Chitnis MM; Gueorguiev M; Norman D; Rosenfelder N; Suliman M; Jones TH; Noonan K; Fabbri A; Besser GM; Burrin JM; Grossman AB
    Clin Endocrinol (Oxf); 2001 Jun; 54(6):781-9. PubMed ID: 11422113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenesis in pituitary adenomas - relationship to endocrine function, treatment and outcome.
    Turner HE; Nagy Z; Gatter KC; Esiri MM; Harris AL; Wass JA
    J Endocrinol; 2000 May; 165(2):475-81. PubMed ID: 10810311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical examination of pituitary adenomas. Comparison to clinical and endocrinological findings.
    Schatz H; Daun M; Leicht R; Stracke H; Saeger W; Zierski J
    Horm Res; 1985; 21(4):246-53. PubMed ID: 2989143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and epidemiological characteristics of pituitary tumours in a single centre in Saudi Arabia.
    Hussein SH; Wahedi TS; Johani NA; Hakami YA; Alzahrani K; AlMalki MH
    Hormones (Athens); 2018 Jun; 17(2):261-267. PubMed ID: 29858852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.